BioSyent Inc. (TSXV:RX)

BioSyent Revenue

BioSyent had revenue of 13.91M CAD in the quarter ending March 31, 2026, with 26.68% growth. This brings the company's revenue in the last twelve months to 45.98M, up 20.13% year-over-year. In the year 2025, BioSyent had annual revenue of 43.05M with 22.90% growth.

• Revenue (ttm): 45.98M
• Revenue Growth: +20.13%
• P/S Ratio: 3.59
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 165.17M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	43.05M	8.02M	22.90%
Dec 31, 2024	35.03M	3.44M	10.89%
Dec 31, 2023	31.59M	3.67M	13.12%
Dec 31, 2022	27.93M	-693.00K	-2.42%
Dec 31, 2021	28.62M	6.29M	28.15%
Dec 31, 2020	22.33M	907.90K	4.24%
Dec 31, 2019	21.42M	-102.70K	-0.48%
Dec 31, 2018	21.53M	764.20K	3.68%
Dec 31, 2017	20.76M	2.84M	15.85%
Dec 31, 2016	17.92M	2.53M	16.47%
Dec 31, 2015	15.39M	3.18M	26.02%
Dec 31, 2014	12.21M	4.41M	56.56%
Dec 31, 2013	7.80M	2.78M	55.24%
Dec 31, 2012	5.02M	2.22M	78.88%
Dec 31, 2011	2.81M	1.13M	67.06%
Dec 31, 2010	1.68M	651.31K	63.24%
Dec 31, 2009	1.03M	-72.09K	-6.54%
Dec 31, 2008	1.10M	-2.34K	-0.21%
Dec 31, 2007	1.10M	-650.43K	-37.07%
Dec 31, 2006	1.75M	905.99K	106.74%
Dec 31, 2005	848.77K	-	-

Data Source: Fiscal.ai Last updated: May 14, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 19, 2026

Data Sources Report a data error